← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

M

$ Value

$0

Shares

15,958

Price

$0

Filed

Dec 19

Insider

Name

Kunkel Lori Anne

Title

CIK

0001536368

Roles

Director

Transaction Details

Transaction Date

2025-12-17

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,741

Footnotes

The shares are held by Lori Kunkel Revocable Trust DTD 11/08/2018 Lori A Kunkel TTEE. | All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Filing Info

Accession No.

0001536368-25-000007

Form Type

4

Issuer CIK

0001672619

Kunkel Lori Anne's History

Date Ticker Type Value
2026-02-12 ELVN A $0
2026-01-02 ORIC A $0
2025-12-17 ELVN M $18K
2025-12-17 ELVN M $0
2025-12-08 ORIC M $79K
2025-12-08 ORIC M $0
2025-12-04 ORIC M $21K
2025-12-04 ORIC M $0
2025-05-19 NRIX A $0

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12